© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Firocoxib, recognized as a selective COX-2 inhibitor, stands out in the world of veterinary pharmaceuticals for managing pain and inflammation in horses and dogs. It enters the scene as a non-steroidal anti-inflammatory drug. Chemically, Firocoxib's molecular structure is defined by the formula C17H20O5S, and its systematic name tells a story of exactness in molecular architecture. Sulfur and oxygen atoms work their way through fused benzofuran and cyclopropylacetyl chains, building a molecule with targeted action, high stability, and low potential for unexpected byproducts.
In practice, Firocoxib often appears as a white to off-white powder or fine crystal, sometimes processed into micropearls or flakes for large-scale distribution. This physical consistency stems from its specific crystalline structure, which delivers not only high purity but also improves shelf-life and precise dosing. With a molecular weight measured at 336.41 g/mol, Firocoxib remains manageable and easy to handle, whether pressed into tablets, packed in vials, or solved in carrier liquids. Its density hovers close to 1.3 g/cm3; this suggests easy weighing and stability during transport and storage, even in bulk. The melting point settles between 191°C and 193°C, which keeps the material solid under typical room temperatures but gives manufacturers an angle for controlled formulation.
Tight controls dictate the moisture content and particle size for Firocoxib. Low hygroscopic nature keeps clumping at bay, protecting the raw material from moisture during processing or storage. Spectroscopic assays commonly guarantee that the product stays above 99% purity, checking for contamination and ensuring safety for vets who trust its consistency. Solubility reflects Firocoxib’s selective utility; it struggles to dissolve in water, pushing formulators to use carriers like ethanol, dimethyl sulfoxide, or propylene glycol for liquid solutions. This specific solubility profile also affects how suspensions and pastes are prepared and dosed in clinical settings. Material forms include bulk powder for compounding, micronized crystals for improved bioavailability, and pearl or flaked presentations that offer low dust, increasing safety in high-throughput environments.
The benzofuran-based molecular skeleton of Firocoxib gives it rigidity and a selective fit for COX-2 enzymes. Safety standards demand hazard labeling typical of pharmacological actives. Direct contact with skin or inhalation of powder raises concerns only in repeated, concentrated exposure, so gloves, masks, and proper fume hoods line every production and repacking facility. MSDS documents flag Firocoxib as non-genotoxic and non-carcinogenic under recommended use, yet highlight the risk to waterways, marking it as not for bulk dumping or uncontrolled discharge. Its environmental stability resists photodegradation but calls for chemical incineration for expired, unusable stock.
For customs clearance, Firocoxib belongs under HS Code 2934999099, sitting broadly among organic pharmaceutical intermediates. Trade happens in kilo- or multi-kilo sealed PE drums or HDPE containers. Commercial buyers look for consistent particle distribution and moisture levels below 0.5%, which answer directly to the needs of industrial mixing and clinical resuspension. Bulk density, usually charted between 0.35 and 0.55 g/mL, determines pour rates on automated filling lines, further supporting precision in finished veterinary pharmaceuticals.
Firocoxib deserves respect through the supply chain. It carries the risk of irritation with repeated, direct exposure, yet poses little health hazard at recommended concentrations. Still, as a chemical active, it belongs far from casual contact with foodstuffs, and away from sites where contamination with open water could occur. Responsible sourcing requires robust documentation, including third-party impurity profiles, heavy metal assays, and compliance checks for antibiotic cross-contamination. Large-scale producers who meet and document GMP compliance, along with ISO-certified handling protocols, build confidence in both veterinarians and regulatory watchdogs. Sourcing from suppliers who commit to these standards supports a reliable supply and a lower risk of adverse events.
Why does this all matter outside the lab? For health professionals working daily with performance or aging animals, every property and material standard impacts dosing, treatability, and safety. Dense, pure Firocoxib behaves predictably in solution or paste, preventing dosage drift and ensuring that animal patients, whether standing in a barn or recovering at a clinic, get the pain relief and recovery support they need. Sourcing, storage, and handling specifications, mapped out in detail here, become not just paperwork, but the backbone of reliable, responsible care in the field.
